$17.34
-0.57-3.17%
Últ. Act.: Sep 1, 8:44 AM
NeoGenomics Inc
NEONASDAQ
NeoGenomics Earnings & Forecasts
NeoGenomics (NEO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NeoGenomics Guidance
NeoGenomics (NEO) publicó su última previsión de julio 28, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $802M - $806M para el período.
En comparación con la previsión anterior, NeoGenomics mantenido redujo su previsión de ingresos desde un rango anterior de $797M - $803M.
NeoGenomics ha emitido 22 actualizaciones de orientación entre el febrero 23, 2023 y el julio 28, 2026. During this period, the company raised its outlook 9 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.01 | $-0.01 |
| Actual | $0.05 | $0.01 | $0.06 | $0.03 |
| Surprise | +400.0% | +150.0% | +500.0% | +400.0% |
| Revenue | ||||
| Estimate | $197.0M | $184.5M | $188.4M | $183.8M |
| Actual | $202.0M | $186.7M | $190.2M | $187.8M |
| Surprise | +2.52% | +1.19% | +0.96% | +2.20% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.04 | $0.05 | $-0.01 | $0.03 |
| Revenue | ||||
| Consensus | $205.8M | $209.7M | — | — |